Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

30.0%

3 terminated/withdrawn out of 10 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

100%

6 of 6 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 3

1(11.1%)

9Total

N/A(8)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03387267Not ApplicableTerminated

Videofluoroscopic Swallowing Study (VFSS)

Role: collaborator

NCT03358810Not ApplicableCompleted

Pharyngeal Electrical Stimulation Evaluation for Dysphagia After Stroke

Role: collaborator

NCT04132466Not ApplicableCompleted

ASSURE WCD Clinical Evaluation - Conversion Efficacy Study

Role: collaborator

NCT03887052Not ApplicableCompleted

ASSURE WCD Clinical Evaluation - Detection and Safety Study

Role: collaborator

NCT03730480Not ApplicableCompleted

User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)

Role: collaborator

NCT02336737Not ApplicableCompleted

SentiMag® Intraoperative Comparison in Breast Cancer

Role: collaborator

NCT00629083Not ApplicableCompleted

Bulking Agents for the Treatment of Stress Urinary Incontinence in Females

Role: collaborator

NCT03752632Phase 3Terminated

Veinplicity for Improved Venous Access: The VIVA Trial

Role: collaborator

NCT03865901Withdrawn

Protocol to Validate the Performance of the Mellitus Glycated CD59 ELISA for Gestational Diabetes Screening

Role: collaborator

NCT03225612Not ApplicableUnknown

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Role: collaborator

All 10 trials loaded